Hussman Strategic Advisors, Inc. Abb Vie Inc. Transaction History

Hussman Strategic Advisors, Inc.

$386 Million
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$133.59 - $154.65 $681,309 - $788,715	-5,100 Reduced 32.69%	10,500 $1.57 Million
Q2 2023 Aug 03, 2023	SELL	$132.51 - $164.9 $397,530 - $494,700	-3,000 Reduced 16.13%	15,600 $2.1 Million
Q1 2023 May 04, 2023	SELL	$144.61 - $166.54 $1.79 Million - $2.07 Million	-12,400 Reduced 40.0%	18,600 $2.96 Million
Q2 2022 Sep 12, 2022	BUY	$137.62 - $174.96 $3.55 Million - $4.51 Million	25,800 Added 496.15%	31,000 $4.75 Million
Q4 2021 Jan 31, 2022	SELL	$107.43 - $135.93 $773,496 - $978,696	-7,200 Reduced 58.06%	5,200 $704,000
Q3 2021 Nov 01, 2021	SELL	$106.4 - $120.78 $329,840 - $374,418	-3,100 Reduced 20.0%	12,400 $1.34 Million
Q2 2021 Aug 03, 2021	SELL	$105.21 - $117.21 $1.4 Million - $1.56 Million	-13,300 Reduced 46.18%	15,500 $1.75 Million
Q1 2021 May 03, 2021	BUY	$102.3 - $112.62 $2.95 Million - $3.24 Million	28,800 New	28,800 $3.12 Million
Q3 2020 Nov 02, 2020	SELL	$85.91 - $100.83 $2.19 Million - $2.57 Million	-25,500 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$73.37 - $98.18 $366,850 - $490,900	5,000 Added 24.39%	25,500 $2.5 Million
Q1 2020 May 01, 2020	BUY	$64.5 - $97.79 $1.32 Million - $2 Million	20,500 New	20,500 $1.56 Million
Q3 2018 Oct 31, 2018	SELL	$88.91 - $98.84 $2.22 Million - $2.47 Million	-25,000 Closed	0 $0
Q2 2018 Jul 31, 2018	BUY	$89.78 - $106.23 $2.24 Million - $2.66 Million	25,000 New	25,000 $2.32 Million
Q1 2018 May 01, 2018	SELL	$92.01 - $123.21 $2.3 Million - $3.08 Million	-25,000 Closed	0 $0
Q4 2017 Jan 31, 2018	BUY	$89.56 - $98.21 $2.24 Million - $2.46 Million	25,000	25,000 $2.42 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.

Account